Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simvastatin in Mild to Moderate TBI
NCT05551871Unknown
- Sponsor
- Assiut University
- Start
- Oct 2022
- Primary completion
- Dec 2023
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial in traumatic brain injury (TBI) comparing Simvastatin with Placebo (2 arms). Primary endpoint: 30-day mortality rate. Status: unknown.
02
Drugs
simvastatin
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT05551871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05551871.